Thor Medical ASA
OSE:TRMED
Intrinsic Value
The intrinsic value of one TRMED stock under the Base Case scenario is 0.093 NOK. Compared to the current market price of 2.195 NOK, Thor Medical ASA is Overvalued by 96%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Thor Medical ASA
Fundamental Analysis

Revenue & Expenses Breakdown
Thor Medical ASA
Balance Sheet Decomposition
Thor Medical ASA
Current Assets | 33.7m |
Cash & Short-Term Investments | 29.6m |
Receivables | 4.1m |
Non-Current Assets | 286.4m |
PP&E | 1.9m |
Intangibles | 284.5m |
Free Cash Flow Analysis
Thor Medical ASA
NOK | |
Free Cash Flow | NOK |
Earnings Waterfall
Thor Medical ASA
Revenue
|
0
NOK
|
Operating Expenses
|
-20.3m
NOK
|
Operating Income
|
-20.3m
NOK
|
Other Expenses
|
-19.3m
NOK
|
Net Income
|
-39.6m
NOK
|
TRMED Profitability Score
Profitability Due Diligence
Thor Medical ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Thor Medical ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
TRMED Solvency Score
Solvency Due Diligence
Thor Medical ASA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Score
Thor Medical ASA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRMED Price Targets Summary
Thor Medical ASA
Dividends
Current shareholder yield for TRMED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TRMED stock under the Base Case scenario is 0.093 NOK.
Compared to the current market price of 2.195 NOK, Thor Medical ASA is Overvalued by 96%.